- ￥1
- Cloud-Clone
- PAA531Hu01
- 2025年07月14日
- WB; IHC; ICC; IP.
- Rabbit
- Human;Mouse
企业认证
相关产品推荐更多 >
Polyclonal Antibody to Phospholipid Scramblase 4 (PLSCR4)-PAD844Hu01
￥1Polyclonal Antibody to Azurocidin (AZU)-PAB461Hu01
￥1Polyclonal Antibody to Coagulation Factor II (F2)-PAA820Ra02
￥1Polyclonal Antibody to MOCO Sulphurase C-Terminal Domain Containing Protein 1 (MOSC1)-PAR574Hu01
￥1Polyclonal Antibody to Cyclophilin 40 (CYP-40)-PAB528Hu01
￥1
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态：
液体
- 保存条件：
-20°
- 克隆性：
Polyclonal antibody preparation
- 适应物种：
Human;Mouse
- 保质期：
12个月
- 库存：
100
- 供应商：
杭州昊鑫生物
- 宿主：
Rabbit
- 应用范围：
WB; IHC; ICC; IP.
- 浓度：
500µg/mL
- 抗体英文名：
Polyclonal Antibody to Plasminogen Activator Inhibitor 2 (PAI2)
- 规格：
10ul（仅限杭州地区终端）
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene
activator inhibitor type-1 [PAI-1]) is an important prognostic factor predicting relapse-free and/or survival in patients with a variety of solid malignant tumors including ovarian cancer; in all cases, high levels of uPA are associated with a poor prognosis (4 -6 ).
The determination of the protein content of urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, in breast cancer tissue extracts is used clinically to identify patients at risk to experience disease recurrence (metastasis
Primary Culture and Differentiation of Human Adipocyte Precursor Cells
in the regulation of energy homeostasis and a variety of neuroendocrine, metabolic, and immune functions (3 -5 ). The cytokines leptin, tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), as well as angiotensinogen and plasminogen activator inhibitor-1 (PAI
技术资料暂无技术资料 索取技术资料
